Rituximab after autologous stem cell transplantation in mantle cell lymphoma patients prolongs survival – 2 Minute Medicine
2 Minute Medicine |
Rituximab after autologous stem cell transplantation in mantle cell lymphoma patients prolongs survival
2 Minute Medicine 1. Patients with mantle cell lymphoma treated with autologous stem cell transplantation experienced greater overall, event-free, and progression-free survival when treated with rituximab maintenance therapy compared to patients not receiving … Adding Drug to Standard Care May Prolong Lymphoma Survival |
